Cargando…

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study

BACKGROUND: Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic metastases are uncommon overall, with mRCC being the most common etiology of pancreatic metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Cassandra, Hu, Junxiao, Beuselinck, Benoit, Panian, Justine, Weise, Nicole, Dizman, Nazli, Collier, Katharine A., Rathi, Nityam, Li, Haoran, Elias, Roy, Martinez-Chanza, Nieves, Rose, Tracy L., Harshman, Lauren C., Gopalakrishnan, Dharmesh, Vaishampayan, Ulka, Zakharia, Yousef, Narayan, Vivek, Carneiro, Benedito A., Mega, Anthony, Singla, Nirmish, Meguid, Cheryl, George, Saby, Brugarolas, James, Agarwal, Neeraj, Mortazavi, Amir, Pal, Sumanta, McKay, Rana R., Lam, Elaine T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248040/
https://www.ncbi.nlm.nih.gov/pubmed/37304495
http://dx.doi.org/10.1016/j.eclinm.2023.102018